Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 12, 2005, Pages 1097-1101

  Cimmino, Mariano ^a   Nardone, Massimiliano ^a   Cavaliere, Matteo ^a   Plantulli, Angela ^a   Sepe, Angela ^a   Esposito, Valeria ^a   Mazzarella, Giuseppina ^a   Raia, Valeria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DORNASE ALFA;

ADOLESCENT; ARTICLE; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; EVALUATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; SCHOOL CHILD; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INTRANASAL; ADOLESCENT; CHILD; CYSTIC FIBROSIS; DEOXYRIBONUCLEASE I; DOUBLE-BLIND METHOD; EXPECTORANTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SINUSITIS; TREATMENT OUTCOME;

EID: 29144516721     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.131.12.1097     Document Type: Article

References (25)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996;154:1229-1256.
2. Koch C, Hoybi N. Pathogenesis of cystic fibrosis. Lancet. 1993;341:1065-1074.
3. Shah PL, Scott SF, Knight RA, Marriott C, Ranasinha C, Hodson ME. In vivo effects of recombinant human Dnase I on sputum in patients with cystic fibrosis. Thorax. 1996;51:119-125.
4. Suri R, Metcalfe C, Lees B, et al. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet. 2001;358:1316-1321.
5. Davies J, Trindade MT, Wallis C, Rosenthal M, Crawford O, Bush A. Retrospective review of the effects of rhDNase in children with cystic fibrosis. Pediatr Pulmonol. 1997;23:243-248.
6. Hui Y, Gaffney R, Crysdale WS. Sinusitis in patients with cystic fibrosis. Eur Arch Otorhinolaryngol. 1995;252:191-196.
7. King V. Upper respiratory disease, sinusitis, and polyposis. Clin Rev Allergy. 1991;9:143-158.
8. Gysin C, Alothman GA, Papsin BC. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol. 2000;30:481-489.
9. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope. 2000;110:1189-1193.
10. Raynor EM, Butler A, Guill M, Bent PB. Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2000;126:581-583.
11. Shwachman H, Kulczycki L. Long-term study of one hundred five patients with cystic fibrosis. AJDC. 1958;96:6-15.
12. Lund VJ, Holmstrom M, Scadding GK. Functional endoscopic sinus surgery in the management of chronic rhino-sinusitis: an objective assessment. J Laryngol Otol. 1991;105:832-835.
13. Klingbeil P, Wiersbitzky S, Bruns R, Ballke EH. The saccarin test in the pediatric broncho-pneumologic outpatient: a non-invasive screening method for the assessment of ciliary function of the respiratory tract in children. Kinderarztl Prax. 1990;58:205-210.
14. Lund VJ, Kennedy DW; The Staging and Therapy Group. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol Suppl. 1995;167:17-21.
15. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis. 1987;136:1285-1298.
16. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med. 1994;331:637-642.
17. Ballmann M, Von der Hardt H. Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis. J Cyst Fibros. 2002;1:35-37.
18. Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol. 1996;21:77-83.
19. Umetsu DT, Moss RB, King VV, et al. Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation. Lancet. 1990;335:1077-1078.
20. Madonna D, Isaacson G, Rosenfeld RM, Panitch H. Effect of sinus surgery on pulmonary function in patients with cystic fibrosis. Laryngoscope. 1997;107:328-331.
21. Nishioka GJ, Cook PR. Paranasal sinus disease in patients with cystic fibrosis. Otolaryngol Clin North Am. 1996;29:193-204.
22. Duplechain JK, White JA, Miller RH. Pediatric sinusitis: the role of endoscopic sinus surgery in cystic fibrosis and other form of sinonasal disease. Arch Otolaryngol Head Neck Surg. 1991;117:422-426.
23. Cepero R, Smith R, Catlin F, Bressler K, Furuta G, Shandera K. Cystic fibrosis: an otorhinolaryngologic perspective. Otolaryngol Head Neck Surg. 1987;97:356-360.
24. Mygind N. Advances in the medical treatment of nasal polyps. Allergy. 1999;54:12-16.
25. Barr MB, Weiss ST, Segal MR, Tager IB, Speizer FE. The relationship of nasal disorders to lower respiratory tract symptoms and illness in a random sample of children. Pediatr Pulmonol. 1992;14:91-94.